ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
84.225
0.33%
US Dollar vs AUD
1.51305
0.15%
Bitcoin
63,001.88
-0.07%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. BioPharmX Corporation (BPMX)

  7. BioPharmX Corporation (BPMX) News

BPMX

BioPharmX (BPMX)

BioPharmX Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:BPMX
DateTimeSourceHeadlineSymbolCompany
29/05/202020:04Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
29/05/202007:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
28/05/202007:23Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:BPMXBioPharmX Corporation
23/05/202007:17Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
20/05/202006:41GlobeNewswire Inc.Timber Pharmaceuticals Announces Investor Conference CallAMEX:BPMXBioPharmX Corporation
16/05/202006:36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
16/05/202006:05PR Newswire (US)BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020AMEX:BPMXBioPharmX Corporation
14/05/202006:33Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
14/05/202006:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
14/05/202006:05PR Newswire (US)BioPharmX Corporation Announces Approval of Merger by Stockholders at Special MeetingAMEX:BPMXBioPharmX Corporation
12/05/202006:09Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
12/05/202006:09Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
08/05/202023:00PR Newswire (US)BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber PharmaceuticalsAMEX:BPMXBioPharmX Corporation
07/05/202020:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
28/04/202006:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:BPMXBioPharmX Corporation
28/04/202006:13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
28/04/202006:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
28/04/202006:05PR Newswire (US)BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 A...AMEX:BPMXBioPharmX Corporation
07/04/202006:55Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
07/04/202006:53Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
07/04/202006:30PR Newswire (US)Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials GrantAMEX:BPMXBioPharmX Corporation
02/04/202007:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:BPMXBioPharmX Corporation
01/04/202021:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
31/03/202007:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
31/03/202007:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:BPMXBioPharmX Corporation
30/03/202021:17Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:BPMXBioPharmX Corporation
26/03/202007:15PR Newswire (US)BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain TradingAMEX:BPMXBioPharmX Corporation
24/03/202007:24Edgar (US Regulatory)Annual Report (10-k)AMEX:BPMXBioPharmX Corporation
20/02/202022:03Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:BPMXBioPharmX Corporation
19/02/202008:04Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
 Showing the most relevant articles for your search:AMEX:BPMX

Your Recent History

NYSE
MRK
Merck
FX
AUDUSD
AUD vs US Dollar
ASX
TLS
Telstra
NYSE
XOM
Exxon Mobil
FX
GBPAUD
Sterling vs AUD
NASDAQ
AMZN
Amazon.com
COIN
ETHUSD
Ethereum
ASX
ANZ
Australia And New Zealan...
FX
AUDCAD
AUD vs CAD
NYSE
MCD
McDonalds
ASX
XFL
S&P ASX 50
COIN
BTCUSD
Bitcoin
ASX
WBC
Westpac Banking
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved